Biocritica, Inc.
Records under this name other than patents Biocritica, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 9 of 9 · Back to Biocritica, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,156,734 | Methods for treating hypercoagulable states or acquired protein C deficiency Term ended Term ended Oct 8, 2019 · From the USPTO record | Term ended | Term ended Oct 8, 2019 | From the USPTO record |
| US 6,159,468 | Activated protein C formulations Term ended Term ended Apr 24, 2018 · From the USPTO record | Term ended | Term ended Apr 24, 2018 | From the USPTO record |
| US 6,162,629 | Methods for processing activated protein C Term ended Term ended Apr 24, 2018 · From the USPTO record | Term ended | Term ended Apr 24, 2018 | From the USPTO record |
| US 6,395,270 | Activated protein C formulations Term ended Ended no later than Apr 24, 2018 · From the USPTO record | Term ended | Ended no later than Apr 24, 2018 | From the USPTO record |
| US 6,436,397 | Activated protein C formulations Term ended Ended no later than Apr 24, 2018 · From the USPTO record | Term ended | Ended no later than Apr 24, 2018 | From the USPTO record |
| US 6,630,137 | Activated protein C formulations Lapsed on the fee record Ended Oct 7, 2015 · From the USPTO record | Lapsed on the fee record | Ended Oct 7, 2015 | From the USPTO record |
| US 7,204,981 | Methods of treating diseases with activated protein C Lapsed on the fee record Ended Apr 17, 2015 · From the USPTO record | Lapsed on the fee record | Ended Apr 17, 2015 | From the USPTO record |
| US 7,638,123 | Methods of treating diseases with activated protein C Lapsed on the fee record Ended Dec 29, 2013 · From the USPTO record | Lapsed on the fee record | Ended Dec 29, 2013 | From the USPTO record |
| US 6,008,199 | Methods for treating hypercoagulable states or acquired protein C deficiency Term ended Term ended no later than Dec 28, 2019 · Low confidence | Term ended | Term ended no later than Dec 28, 2019 | Low confidence |